There were 87 seroconversions, leading to a standard HSV-2 incidence rate of 15.5 cases per 100 person-years . Aftereffect of Tenofovir Gel on HSV-2 Incidence The HSV-2 incidence rate among women who had been assigned to tenofovir gel was 10.2 situations per 100 person-years , in comparison with 21.0 cases per 100 person-years among women who had been assigned to placebo gel . The incidence price ratio ranged from 0.48 to 0.51 in the sensitivity analyses that treated equivocal ELISA results from enrollment and exit samples while either negative or positive . In an as-treated post hoc analysis that was based on gel use through the trial, tenofovir gel was associated with a 71 percent lower risk of HSV-2 acquisition among women who used a lot more than six gel applicators per month, a 52 percent lower risk among women who used 4-6 applicators monthly, and a 27 percent lower risk among women who used less than four applicators monthly.Serious adverse occasions, deaths, and AIDS events were examined by two clinicians who weren’t alert to the study-group assignments. Level of resistance mutations were classified according to the algorithm used by the Stanford University HIV Drug Resistance Database, april 2011 and HIV subtype was determined based on the Rega Institute system22 in March and.K. Individuals with subtype B. All assays were performed in duplicate. Statistical Analysis Based on data from the CASCADE study,24 we calculated that people would have to enroll 360 patients to be able to provide 90 percent power to detect a relative decrease in the risk of progression to the initial primary end point of 50 percent with 48-week Artwork and 25 percent with 12-week ART, in comparison with standard care, at a significance degree of 5 percent.